These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17922408)

  • 1. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection.
    Lupetti A; Brouwer CP; Bogaards SJ; Welling MM; de Heer E; Campa M; van Dissel JT; Friesen RH; Nibbering PH
    J Infect Dis; 2007 Nov; 196(9):1416-24. PubMed ID: 17922408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
    J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of human lactoferrin in experimentally induced systemic candidiasis.
    Velliyagounder K; Rozario SD; Fine DH
    J Med Microbiol; 2019 Dec; 68(12):1802-1812. PubMed ID: 31702539
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin.
    Lupetti A; Brouwer CP; Dogterom-Ballering HE; Senesi S; Campa M; Van Dissel JT; Nibbering PH
    J Antimicrob Chemother; 2004 Sep; 54(3):603-8. PubMed ID: 15282237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
    Wang Y; Jia XM; Jia JH; Li MB; Cao YY; Gao PH; Liao WQ; Cao YB; Jiang YY
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e40-6. PubMed ID: 19413603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
    Shi J; Li S; Gao A; Zhu K; Zhang H
    Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
    Petraitiene R; Petraitis V; Kelaher AM; Sarafandi AA; Mickiene D; Groll AH; Sein T; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2005 May; 49(5):2084-92. PubMed ID: 15855534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis.
    Lee JH; Jang EC; Han Y
    Arch Pharm Res; 2011 Mar; 34(3):399-405. PubMed ID: 21547671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidacidal activities of human lactoferrin peptides derived from the N terminus.
    Lupetti A; Paulusma-Annema A; Welling MM; Senesi S; van Dissel JT; Nibbering PH
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3257-63. PubMed ID: 11083624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial αβ region.
    Kondori N; Baltzer L; Dolphin GT; Mattsby-Baltzer I
    Int J Antimicrob Agents; 2011 Jan; 37(1):51-7. PubMed ID: 21075607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics produced by Streptomyces olivaceus 142. Antifungal properties of antibiotic WR-142 FPG.
    Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):433-9. PubMed ID: 383040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole resistance in Candida albicans: a review of mechanisms.
    Casalinuovo IA; Di Francesco P; Garaci E
    Eur Rev Med Pharmacol Sci; 2004; 8(2):69-77. PubMed ID: 15267120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.